The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection

• Nigel Klein ,

  * E-mail: n.klein@ucl.ac.uk

  Affiliation Institute of Child Health, University College London, London, United Kingdom

  ⨯
• Delali Sefe,

  Affiliation Institute of Child Health, University College London, London, United Kingdom

  ⨯
• Ilaria Mosconi,

  Affiliation AIDS Reference Center, University of Padova, Padova, Italy

  ⨯
• Marisa Zanchetta,

  Affiliation AIDS Reference Center, University of Padova, Padova, Italy

  ⨯
• Hannah Castro,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Marianne Jacobsen,

  Affiliation Institute of Child Health, University College London, London, United Kingdom

  ⨯
• Hannah Jones,

  Affiliation Institute of Child Health, University College London, London, United Kingdom

  ⨯
• Stefania Bernardi,

  Affiliation Ospedale del Bambino Gesù, Rome, Italy

  ⨯
• Deenan Pillay,

  Affiliation University College London/Medical Research Council Centre for Medical Molecular Virology, University College London Medical School, London, United Kingdom

  ⨯
• Carlo Giaquinto,

  Affiliation Department of Paediatrics, University of Padova, Padova, Italy

  ⨯
• A. Sarah Walker,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Diana M. Gibb,

  Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom

  ⨯
• Anita De Rossi,

  Affiliation AIDS Reference Center, University of Padova, Padova, Italy

  ⨯
• on Behalf of the Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial Team

  ¶Membership of the Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial Team is provided in the Acknowledgments.

  ⨯